Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Health Econ. 2019 Jan 29;28(4):517–528. doi: 10.1002/hec.3860

Appendix Table A8.

Distribution of drugs used to treat leukemia

Rank
by frequency
Before integration After integration
HCPCS_CD Average payment ($) HCPCS_CD Average payment ($)
1 J9310 $4,453 J9310 $4,453
2 J9025 $883 J9025 $883
3 J9033 $2,797 J9033 $2,797
4 J9185 $114 J9185 $114
5 J9070 $167 J9070 $167
6 J9017 $522 J9010 $1,648
7 J9370 $4 J9017 $522
8 J9217 $742 J9302 $7,628
9 J9209 $69 J9370 $4
10 J9302 $7,628 J9041 $1,282
11 J9208 $85 J9217 $742
12 J9181 $4 J9201 $583
13 J9355 $2,891 J9250 $0
14 J9999 $3,216 J9000 $10
15 J9000 $10 J9035 $6,079
16 J9045 $18 J9181 $4
17 J9091 $44 J9268 $1,050
18 J9201 $583 J9045 $18
19 J9390 $21 J9100 $10
20 J9035 $6,079 J9190 $15

Notes:

The distribution of the drugs (ranked by frequency) among leukemia patients;

HCPCS_CD: Healthcare Common Procedure Coding System (HCPCS) Level II (J-code) for a chemotherapy agent.